|
CBWD2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.146190E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.113500E-02 |
| Normal-vs-Stage2 |
4.128000E-02 |
| Normal-vs-Stage3 |
1.036350E-03 |
| Normal-vs-Stage4 |
6.479300E-03 |
| Stage1-vs-Stage2 |
4.287800E-01 |
| Stage1-vs-Stage3 |
7.400000E-02 |
| Stage1-vs-Stage4 |
1.843640E-01 |
| Stage2-vs-Stage3 |
4.830200E-01 |
| Stage2-vs-Stage4 |
4.953800E-01 |
| Stage3-vs-Stage4 |
8.310200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.106090E-02 |
| Normal-vs-AfricanAmerican |
3.746600E-01 |
| Normal-vs-Asian |
5.665900E-02 |
| Caucasian-vs-AfricanAmerican |
1.653370E-01 |
| Caucasian-vs-Asian |
5.842800E-01 |
| AfricanAmerican-vs-Asian |
3.257000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.301000E-03 |
| Normal-vs-Female |
5.407000E-01 |
| Male-vs-Female |
1.191630E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.363420E-01 |
| Normal-vs-Extreme_Weight |
5.776000E-03 |
| Normal-vs-Obese |
3.944200E-02 |
| Normal-vs-Extreme_Obese |
6.150200E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.478200E-01 |
| Normal_Weight-vs-Obese |
5.863800E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.613400E-01 |
| Extreme_Weight-vs-Obese |
6.546800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.186200E-01 |
| Obese-vs-Extreme_Obese |
4.175400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.754800E-01 |
| Normal-vs-Age(41-60Yrs) |
1.717800E-02 |
| Normal-vs-Age(61-80Yrs) |
1.700130E-02 |
| Normal-vs-Age(81-100Yrs) |
5.818400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.968600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.148800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.493400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.538800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.643800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.807600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.453700E-02 |
| Normal-VS-Type2 PRCC |
7.719500E-03 |
| Normal-VS-KIRP CIMP |
3.226900E-04 |
| Normal-VS-Unclassified PRCC |
4.882500E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.599010E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.013600E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
5.006800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.802650E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
7.063000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
8.040200E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.639700E-03 |
| Normal-vs-N1 |
6.782400E-02 |
| Normal-vs-N2 |
1.095780E-03 |
| N0-vs-N1 |
9.285600E-01 |
| N0-vs-N2 |
1.749820E-01 |
| N1-vs-N2 |
2.126200E-01 |
|
|
